The Korean Journal of Medicine

  • 제87권5호
  • /
  • Pages.598-602
  • /
  • 2014
  • /
  • 1738-9364(pISSN)
  • /
  • 2289-0769(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지
DOI QR코드

DOI QR Code

아급성 관상동맥 스텐트 혈전증에서 Ticagrelor를 사용한 1예

A Case of Ticagrelor Rescue Therapy in a Patient with Subacute Stent Thrombosis

  • 고준권 (한양대학교 의과대학 내과학교실) ;
  • 김지숭 (한양대학교 의과대학 내과학교실) ;
  • 정승준 (한양대학교 의과대학 내과학교실) ;
  • 김성종 (한양대학교 의과대학 내과학교실) ;
  • 김병식 (한양대학교 의과대학 내과학교실) ;
  • 김유신 (한양대학교 의과대학 내과학교실) ;
  • 신정훈 (한양대학교 의과대학 내과학교실)
  • Ko, Jun Kwon (Departments of Internal Medicine, Hanyang University College of Medicine) ;
  • Kim, Ji Soong (Departments of Internal Medicine, Hanyang University College of Medicine) ;
  • Chung, Sung Jun (Departments of Internal Medicine, Hanyang University College of Medicine) ;
  • Kim, Seong Jong (Departments of Internal Medicine, Hanyang University College of Medicine) ;
  • Kim, Byung Sihk (Departments of Internal Medicine, Hanyang University College of Medicine) ;
  • Kim, You Shin (Departments of Internal Medicine, Hanyang University College of Medicine) ;
  • Shin, Jeong Hun (Departments of Internal Medicine, Hanyang University College of Medicine)
  • 투고 : 2014.10.13
  • 심사 : 2014.02.24
  • 발행 : 2014.11.01
⟨ 이전 논문 다음 논문 ⟩

초록

뇌졸중으로 아스피린과 클로피도그렐을 복용하던 71세 남자 환자에서 급성 하벽 심근경색증으로 관상동맥 중재술을 시행하였다. 시술 7일째 급성 호흡곤란 및 ST분절 상승소견으로 시행한 관상동맥 조영술에서 스텐트 혈전증을 진단 후 중재술을 시행하였다. 혈소판 기능 검사에서 Clopidogrel 저항성이 확인하였고 뇌졸중 과거력을 고려해 Ticagrelor로 구조요법(rescue therapy)을 시행한 증례를 경험하였기에 문헌고찰과 함께 보고하는 바이다.

Stent thrombosis (ST) is a rare but catastrophic complication of a drug-eluting stent. Although dual antiplatelet therapy with aspirin and clopidogrel significantly reduces the occurrence of ST, it continues to occur and is occasionally associated with clopidogrel resistance. Here, we describe a 71-yr-old man with subacute stent thrombosis and clopidogrel resistance following drug-eluting stent implantation who underwent successful ticagrelor rescue therapy.

키워드

참고문헌

  1. O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013;127:e362-425. https://doi.org/10.1161/CIR.0b013e3182742cf6
  2. Matetzky S, Shenkman B, Guetta V, et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 2004;109:3171-3175. https://doi.org/10.1161/01.CIR.0000130846.46168.03
  3. Serebruany VL, Steinhubl SR, Berger PB, Malinin AI, Bhatt DL, Topol EJ. Variability in platelet responsiveness to clopidogrel among 544 individuals. J Am Coll Cardiol 2005;45:246-251. https://doi.org/10.1016/j.jacc.2004.09.067
  4. Bonello L, Tantry US, Marcucci R, et al. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol 2010;56:919-933. https://doi.org/10.1016/j.jacc.2010.04.047
  5. Kim IS, Choi BR, Jeong YH, Kwak CH, Kim S. The CYP2C19*2 and CYP2C19*3 polymorphisms are associated with high post-treatment platelet reactivity in Asian patients with acute coronary syndrome. J Thromb Haemost 2009;7:897-899. https://doi.org/10.1111/j.1538-7836.2009.03319.x
  6. Park KW, Kim HS. Stent thrombosis in the DES era. Korean J Med 2008;75:383-391.
  7. Geisler T, Zurn C, Simonenko R, et al. Early but not late stent thrombosis is influenced by residual platelet aggregation in patients undergoing coronary interventions. Eur Heart J 2010;31:59-66. https://doi.org/10.1093/eurheartj/ehp402
  8. Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007;357:2001-2015. https://doi.org/10.1056/NEJMoa0706482
  9. Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009;361:1045-1057. https://doi.org/10.1056/NEJMoa0904327
  10. Kang MK, Chang K. New oral antiplatelet agents. Korean J Med 2013;85:10-14. https://doi.org/10.3904/kjm.2013.85.1.10